Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 4
Submit an article Journal homepage
64
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Hemodynamic Effects of a Combination of Octreotide and Terlipressin Patients with Viral Hepatitis Related Cirrhosis

H.-C. Lin
,
Y.-Y. Yang
,
M.-C. Hou
,
Y.-T. Huang
,
W.-C. Lee
,
F.-Y. Lee
,
F.-Y. Chang
&
S.-D. Lee
 show all
Pages 482-487 | Published online: 08 Jul 2009

  • Bosch J, Groszmann RJ, editors. Portal hypertension: pathophysiology and treatment. Oxford: Blackwell; 1994.
  • Lebrec D, Fleury RD, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980;79:1139-44.
  • Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophagea 1 varices and variceal bleeding. Hepatology 1985;5:419-24.
  • Lebrec D. Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding. Pharmacol Ther 1994;61:65-107.
  • D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-54.
  • Bosch J. Medical treatment of portal hypertension. Digestion 1998;59:547-55.
  • Groszmann RJ, Kravetz D, Bosch J, Glickman M, Bruix J, Bredfeldt J, et al. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 1982; 2:757-62.
  • Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, et al. Systemic and portal hemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis. J Hepatol 1990;10:370-4.
  • Lee FY, Tsai YT, Lin HC, Lee SD, Hsia HC, Lin WJ, et al. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis B-related cirrhosis. J Hepatol 1992;15:54-8.
  • Garcia-Pagan JC, Feu F, Bosch J,Rodés J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. Ann Intern Med 1991;114:869-73.
  • Albillos A, Garcia-Pagan JC, Iborra J, Bandi JC, Cacho G, PerezParamo M, et al. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension. Gastroenterology 1998;115:116-23.
  • Lin HC, Tsai YT, Yang MCM, Hou MC, Lee FY, Chen LS, et al. Haemodynamic effects of a combination of propranolol and clonidine in patients with post-hepatitic cirrhosis. J Gastroenterol Hepatol 1995;10:281-6.
  • Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octieotide for acute esophageal bleeding: a meta-analysis. Gastroenterology 2001;120:946-54.
  • Blei AT, Groszmann RJ, Gusberg R, Conn H. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs. Dig Dis Sci 1980;25:688-94.
  • Lebrec D, Moreau R, Cailmail S, Sogni P, Oberti F, Hadengue A. Effects of terlipressin on hemodynamic s and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol. J Hepatol 1993;17:102-7.
  • Rabø1 A, Juhl E, Schmidt A, Winkler K. The effect of vasopressi n and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension. Digestion 1976;14:285-9.
  • Merkel C, Gatta A, Bolognesi M, Finuicci G, Battaglia G, Angeli P, et al. Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis. Dig Dis Sci 1988;33:1103-9.
  • Møller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000;20:51-9.
  • Eriksson LS, Brundin T, Söderlund C, Wahren J. Hemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987;22:919-25.
  • Møller S, Brinch K, Henriksen JH, Becker U. Effect of octreotide on systemic, central and splanchnic hemodynamic s in cirrhosis. J Hepatol 1997;26:1026-33.
  • Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, et al. Hemodynamic evaluation of octreotide in patients with hepatitis B related cirrhosis. Gastroenterology 1992;103:229-34.
  • McCormick PA, Dick R, Siringo S, Wagstaff D, Chesta J, Mclntyre N, et al. Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990;2:489-92.
  • Sieber CC, Mosca PG, Groszmann RJ. Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats. Am J Physiol 1992;262:G274-7.
  • Pizcueta MP, García-Pagín JC, Femândez M, Casamitjana R, Bosch J, Rodes J. Glucagon hinders the effects of somalostatinon portal hypertension. A study in rats with partial portal vein ligation. Gastroenterology 1991;101:1710-5.
  • Lin HC, Yang MCM, Hou MC, Li SM, Huang YT, Yu PC, et al. Effects of long-term administration of octreotide in portal hypertensive rats. Hepatology 1996;23:537-43.
  • Huang YT, Tsai JF, Liu TB, Hong CY, Yang MCM, Lin HC. Chronic administration of octreotide increases vascular responsiveness in rats with portal hypertension. Clin Sci 1996;91: 606-6.
  • Sieber CC, Lee FY, Groszmann RJ. Long-term octieotide treatment prevents vascular hyporeactivity in portal hypertensive rats. Hepatology 1996;23:1218-23.
  • Moreau R, Cailmail S, Valla D, Lebrec D. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats. Aliment Pharmacol Ther 1997;11:993-7.
  • Oberti F, Veal N, Kaassis M, Pilette C, Rifflet H, Trouve R, et al. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. J Hepatol 1998:29:103-11.
  • Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R. Transection of oesophagus for bleeding oesophageal varices. Br J Surgi 1973;60:646-9.
  • Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, et al. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis. J Hepatol 1989;9: 326-30.
  • Perello A, Escorsell A, Bru C, Gilabert R, Moitinho E, GarciaPagan JC, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 1999;30:1393-7.
  • Forrester JS, Ganz W, Diamond G, McHugh T, Chonette DW, Swan HJC. Thermodilution cardiac output determination with a single flow-directed catheter. Am Heart J 1972;83:306-11.
  • Merkel C, Bianco S, Bolognesi M, Garegaro L, Amodio P, Sacerdoti D. Effect of triglycyl-lysin-vasopressi n on quantitative liver function tests in patients with cirrhosis. Am J Gastroenterol 1992;87:1580-6.
  • Winkler K, Bass L, Keiding S. The physiological basis for clearance measurements in hepatology. Scand J Gastroenterol 1979;14:439-48.
  • Albillos A, Colombato LA, Lee FY, Groszmann RJ. Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats. Gastroenterology 1993;104:575-9.
  • Fort J, Oberti F, Pilette C, Veal N, Gallois Y, Douay O. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology 1998;28:1525-31.
  • Yang YY, Lin HC, Huang YT, Lee TZ, Hou MC, Lee FY, et al. Adaptive vasodilatory response of octreotide in cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 2001;281:G117-23.
  • Lin HC, Tsai YT, Yang MCM, Lee FY, Hou MC, Chen LS, et al. Effect of octreotide on total effective vascular compliance in patients with post-hepatitic cirrhosis. J Hepatol 1996;24:81 -7.
  • Escorsell A, Bandi JC, Andreu V, Moitinho E, Garcia-Pagan JC, Bosch J, et al. Desensitization of the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 2001;120:161 -9.
  • Pringle SD, McKee RF, Garden OJ, Lorimer AR, Carter DC. The effect of a long-acting somatostatin analogue on portal and systemic hemodynamic s in cirrhosis. Aliment Pharmacol Ther 1988;2:451-9.
  • McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, Mclntyre N, et al. Cardiovascular effects of octreotide in patients with cirrhosis. Hepatology 1995;21:1255-60.
  • Webb SC, Kirikler DM, Hendry WG, Adrian TE, Bloom SR. Electrophysiolpgical actions of somatostatin on the atrioventricular junction in sinus rhythm and reentry tachycardia. Br Heart J 1986;56:236-41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.